We're opening soonWe're opening soon. Sign up and get notified the moment we go live.
Get notified when we launch
10% off the entire range with codeLAUNCH10
Ordered before 16:00 = shipped the same day · 1-2 business days delivery within the Netherlands · Discreet shipping · Free shipping from €75 (NL/BE) / €150 (EU)
Research guide

PT-141 (Bremelanotide)

PT-141 (bremelanotide) is a synthetic melanocortin analogue derived from Melanotan II. It is studied in preclinical research in relation to central melanocortin signalling and sexual function.

Shipped from the Netherlands≥ 99% purity

What is PT-141 (Bremelanotide)?

PT-141 (bremelanotide) is a synthetic melanocortin analogue derived from Melanotan II. It is studied in preclinical research in relation to central melanocortin signalling and sexual function. This page is intended solely as an informational research guide for laboratory applications (Research Use Only).

Mechanism (preclinical)

Non-selective agonist of melanocortin receptors (primarily MC3R and MC4R) in the central nervous system in preclinical models.

Research areas

  • Sexual function in preclinical models
  • Central melanocortin signalling
  • MC3R/MC4R receptor research

Specifications

CAS
189691-06-3
Molecular formula
C50H68N14O10
Molecular weight
1025,18 g/mol
Purity
≥ 99%
Form
Lyophilised powder
Included
3 ml bacteriostatic water

Storage and reconstitution

Dry (lyophilised) powder can be stored long-term at -20 to -80 °C in an airtight, opaque container. After reconstitution with bacteriostatic water the solution must be refrigerated at 2 to 8 °C and protected from light.

Order PT-141 (Bremelanotide) from Europa Peptides

Europa Peptides supplies PT-141 (Bremelanotide) as lyophilised powder with ≥ 99% purity - 3 ml bacteriostatic water included. Shipped from our Netherlands warehouse. Orders placed before 16:00 on a business day ship the same day. For laboratory research only (RUO).

Important (RUO): This product is intended solely for in-vitro/in-vivo laboratory research by qualified scientific personnel. All information above describes associations from peer-reviewed preclinical literature and does not constitute a recommendation for any other application.